2004年我院肾移植患者免疫抑制剂应用分析

目的:了解近期我院肾移植患者住院期间免疫抑制剂应用情况。方法:回顾性查阅2004年我院肾移植病历124份,对免疫抑制剂品种及相关费用进行统计,并与2000年结果进行比较分析。结果:患者2004年平均住院费用74462.77元,应用免疫抑制剂平均费用25809.93元,较2000年分别增长75.12%、175.35%;免疫抑制剂费用占总药费的比例平均为61.37%,而2000年为46.4%;免疫抑制剂使用频率2004年排序前3位的品种分别为甲泼尼龙、环孢素A、泼尼松。结论:与2000年相比,2004年我院肾移植患者新型免疫抑制剂应用品种及费用增加,因而寻找更有效、不良反应更少、更价廉的免疫抑制剂治疗方案具有重要意义。

Immunosuppressive Agents for Renal Transplantation Patients in Our Hospital in 2004: Drug Use Analysis

OBJECTIVE:To investigate the recent use of immunosuppressive agents for renal transplantation patients during our hospital.METHODS:Case history of124renal transplantation patients in our hospital in2004was reviewed ret-rospectively,and the categories and the associated costs of immunosuppressive agents were statistically analyzed,which were compared with that of2000.RESULTS:In2004,patients’mean hospitalization cost was74462.77yuan and mean immuno-suppressive agents cost was25809.93yuan,increased by75.12%and175.35%,respectively as compared to2000.Of the total drug costs,the immunosuppressive agents accounted for61.37%in2004and46.4%in2000.Dominated the first3places in the list of DDDs of immunosuppressive agents in2004were Methylprednisolone,ciclosporin A and dehydrocortisone,respec-tively.CONCLUSIONS:As compared with2000,the application categories and costs of neotype immunosuppressive agents for renal transplantation patients in our hospital increased in2004,thus to find a more effective immunosuppressive remedy that of less adverse drug reaction and lower cost is of great significance.